These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24746310)

  • 1. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pityriasis rubra pilaris successfully treated with adalimumab.
    Schreml S; Zeller V; Babilas P; Karrer S; Landthaler M; Szeimies RM
    Clin Exp Dermatol; 2010 Oct; 35(7):792-3. PubMed ID: 20345992
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatment.
    O'Kane D; Devereux CE; Walsh MY; Hoey SE
    Clin Exp Dermatol; 2010 Jun; 35(4):e155-6. PubMed ID: 19925485
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy.
    Müller H; Gattringer C; Zelger B; Höpfl R; Eisendle K
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S65-70. PubMed ID: 19119128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
    Maloney NJ; Hisaw LD; Worswick S
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin.
    Chastagner M; Hoelt P; Kanitakis J; Jullien D; Villani AP
    Eur J Dermatol; 2019 Apr; 29(2):218-220. PubMed ID: 30827945
    [No Abstract]   [Full Text] [Related]  

  • 9. Type I pityriasis rubra pilaris: upregulation of tumor necrosis factor alpha and response to adalimumab therapy.
    Zhang YH; Zhou Y; Ball N; Su MW; Xu JH; Zheng ZZ
    J Cutan Med Surg; 2010; 14(4):185-8. PubMed ID: 20642989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept.
    Guedes R; Leite L
    Dermatol Ther; 2011; 24(2):285-6. PubMed ID: 21410618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pityriasis rubra pilaris].
    Quenan S; Laffitte E
    Ann Dermatol Venereol; 2018 Jan; 145(1):50-59. PubMed ID: 29290415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis rubra pilaris responding rapidly to adalimumab.
    Walling HW; Swick BL
    Arch Dermatol; 2009 Jan; 145(1):99-101. PubMed ID: 19153364
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab.
    Manoharan S; White S; Gumparthy K
    Australas J Dermatol; 2006 May; 47(2):124-9. PubMed ID: 16637810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Pityriasis rubra pilaris with brodalumab.
    De Rosa A; Gambardella A; Licata G; Alfano R; Argenziano G
    Australas J Dermatol; 2020 May; 61(2):e249-e251. PubMed ID: 31851372
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of Wong's dermatomyositis.
    Caporali R; Cavagna L; Bellosta M; Bogliolo L; Montecucco C
    Clin Rheumatol; 2004 Feb; 23(1):63-5. PubMed ID: 14749988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?
    Ivanova K; Itin P; Haeusermann P
    Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%.
    Gregoriou S; Argyriou G; Christofidou E; Vranou A; Rigopoulos D
    J Drugs Dermatol; 2007 Mar; 6(3):340-2. PubMed ID: 17373199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ustekinumab treatment of pityriasis rubra pilaris: A report of five cases.
    Napolitano M; Lembo L; Fania L; Abeni D; Didona D; Didona B
    J Dermatol; 2018 Feb; 45(2):202-206. PubMed ID: 29080273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
    Lu R; George SJ; Hsu S
    Dermatol Online J; 2006 May; 12(4):18. PubMed ID: 17083873
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of severe pityriasis rubra pilaris with secukinumab in a 3-year-old boy.
    Xu YH; Dong DD; Lin YF; Wang Q; Huang LM; Shi JQ
    Clin Exp Dermatol; 2022 Nov; 47(11):2043-2045. PubMed ID: 35906074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.